Motor nerve conduction study and muscle strength in newly diagnosed poems syndrome

Muscle and Nerve

Volumn 51, Issue 1, 2015, Pages 19-23

  Liu, Mingsheng ^a   Zou, Zhangyu ^a   Guan, Yuzhou ^a   Li, Jian ^a   Zhou, Daobin ^a   Cui, Liying ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Axonal loss; Demyelination; Motor nerve conduction study; Muscle strength; POEMS syndrome

Indexed keywords

ACTION POTENTIAL; ADULT; AGED; ELECTROMYOGRAPHY; ELECTROSTIMULATION; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MUSCLE STRENGTH; NERVE CONDUCTION; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; POEMS SYNDROME; SEVERITY OF ILLNESS INDEX; SPINAL NERVE;

ACTION POTENTIALS; ADULT; AGED; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; NEURAL CONDUCTION; POEMS SYNDROME; SEVERITY OF ILLNESS INDEX; SPINAL NERVES; STATISTICS, NONPARAMETRIC;

EID: 84916931772     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24267     Document Type: Article

References (14)

1. Li J, Zhou DB, Huang Z, Jiao L, Duan MH, Zhang W, et al. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China. Ann Hematol 2011;90:819-826.
2. Kelly JJ Jr, Kyle RA, Miles JM, Dyck PJ. Osteosclerotic myeloma and peripheral neuropathy. Neurology 1983;33:202-210.
3. Nasu S, Misawa S, Sekiguchi Y, Shibuya K, Kanai K, Fujimaki Y, et al. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2012;83:476-479.
4. Mauermann ML, Sorenson EJ, Dispenzieri A, Mandrekar J, Suarez GA, Dyck PJ, et al. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP. J Neurol Neurosurg Psychiatry 2012;83:480-486.
5. Sung JY, Kuwabara S, Ogawara K, Kanai K, Hattori T. Patterns of nerve conduction abnormalities in POEMS syndrome. Muscle Nerve 2002;26:189-193.
6. Min JH, Hong YH, Lee KW. Electrophysiological features of patients with POEMS syndrome. Clin Neurophysiol 2005;116:965-968.
7. Sobue G, Doyu M, Watanabe M, Hayashi F, Mitsuma T. Extensive demyelinating change in the peripheral nerves of Crow-Fukase syndrome: a pathological study of one autopsied case. Acta Neuropathol 1992;84:171-177.
8. Scarlato M, Previtali SC, Carpo M, Pareyson D, Briani C, Del Bo R, et al. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain 2005;128:1911-1920.
9. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, et al. POEMS syndrome: definitions and long-term outcome. Blood 2003;101:2496-2506.
10. Li J, Zhang W, Jiao L, Duan MH, Guan HZ, Zhu WG, et al. Combination of melphalan and dexamethasone for patients with newly-diagnosed POEMS syndrome. Blood 2011;117:6445-6449.
11. Løseth S, Nebuchennykh M, Stålberg E, Mellgren SI. Medial plantar nerve conduction studies in healthy controls and diabetics. Clin Neurophysiol 2007;118:1155-1161.
12. Olney RK. Consensus criteria for the diagnosis of partial conduction block. Muscle Nerve 1999;22(suppl 8):s225-229.
13. Vallat JM, Magy L, Richard L, Sturtz F, Couratier P. Contribution of electron microscopy to the study of neuropathies associated with an IgG monoclonal paraproteinemia. Micron 2008;39:61-70.
14. Dispenzieri A. POEMS syndrome: update on diagnosis, risk-stratification, and management. Am J Hematol 2012;87:805-814.